Serina Therapeutics (SER)

Serina Therapeutics (SER) Financial Statements


Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently ―. The company's EPS TTM is $-14.064; its P/E ratio is -0.63; Serina Therapeutics is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 56.00K$ 9.00K$ 10.00K$ 8.00K$ 9.00K
Gross Profit$ 55.00K$ 4.00K$ 9.00K$ 7.00K$ 4.00K
EBIT$ -3.47M$ -1.89M$ 2.14M$ -1.78M$ -1.51M
EBITDA$ -3.32M$ -936.00K$ 3.23M$ -834.00K$ -1.48M
Net Income Common Stockholders$ -3.46M$ -2.67M$ -2.23M$ -2.70M$ -2.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 345.00K$ 261.00K$ 280.00K$ 645.00K$ 466.00K
Total Assets$ 11.96M$ 12.28M$ 12.53M$ 3.24M$ 2.01M
Total Debt$ 4.37M$ 33.01M$ 30.05M$ 18.12M$ 15.65M
Net Debt$ 4.02M$ 32.75M$ 29.77M$ 17.48M$ 15.18M
Total Liabilities$ 6.61M$ 34.34M$ 32.54M$ 20.56M$ 17.16M
Stockholders Equity$ 5.47M$ -22.18M$ -19.89M$ -17.21M$ -15.10M
Cash Flow-
Free Cash Flow$ -2.05M$ -2.02M$ -1.86M$ -1.32M$ -1.24M
Operating Cash Flow$ -2.05M$ -2.02M$ -1.86M$ -1.32M$ -1.24M
Investing Cash Flow--$ -10.00M-$ 0.00
Financing Cash Flow$ 2.00M$ 2.00M$ 11.50M$ 1.50M$ 1.00M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis